StonkScan
OverviewRevenueFinancialsValuationOutlookOwnership
Price
Performance · vs S&P 500
Company
Target Corporation
NYSE · USD
Large cap
0.77× peer median
0.36× peer median
Moves with market
Claude reads this page's data and writes up Target Corporation's financials, valuation and analyst coverage: built only from the figures here, with nothing pulled in from elsewhere.
Generated by an AI model from the data on this page. It can be wrong, and it isn't investment advice or a recommendation to buy or sell anything. Check every figure against the sections themselves before you rely on it.
$20.0B of current assets against $21.2B due within a year: a shortfall of $1.2B.
Liquidity · FY25
8.4% in FY21 to 4.9% in FY25.
Profitability · FY25
$106.0B in FY21 to $104.8B in FY25, with the latest year down 1.7%.
Growth · FY25
$11.0B of net debt against $6.6B of annual operating cash flow.
Liquidity · FY25
$14.7B of free cash flow against $21.7B of net income across 5 fiscal years.
Quality · FY25
Free cash flow of $2.8B covers the business without outside capital, on $5.5B of cash and short-term investments.
Liquidity · FY25
$104.8B of revenue against $99.6B of operating costs, leaving $5.1B.
Profitability · FY25
Revenue came in above consensus by 1.1% on average over the last four reports.
Quality · Aug '26
Martin Shkreli, known as Pharma Bro, said Ultragenyx Pharmaceutical (NASDAQ:RARE) is undervalued and a potential takeover target for rare-disease peers like BioMarin Pharmaceuticals (NASDAQ:BMRN) after a trial setback.
Robinhood Markets (NASDAQ:HOOD | HOOD Price Prediction) stock is rallying 11% to $118.88 in Thursday trading as a series of bullish analyst calls reinforces the case that Robinhood is becoming more than a traditional retail brokerage.
Target expands its beauty strategy with Beauty Studio launching on Sept. 10 in 600+ stores, featuring 1,600+ products from 90 brands.
Meta's stock is down sharply, capex is ballooning toward $145 billion, and Wall Street's average target stops well short of four digits. So what would actually need to happen for shares to reach $1,000 by 2027?
AST pushed back its target of 45 satellites from late 2026 to early 2027. That delay is disappointing, but it still has plenty of irons in the fire.
Somnigroup International NYSE: SGI said it has completed its acquisition of Leggett & Platt, expanding its vertical integration in bedding components while adding businesses serving automotive, furniture, geocomponents and hydraulic-cylinder markets.
Average month-end to month-end move for TGTin each calendar month. Point at a bar for that month's spread: past seasonality is a tendency in a small sample, not a forecast.
−$1.8B vs FY24
FY24 → FY25
FY21 → FY25, annualized
+2.0% vs the four before
Q2 FY26 · +5.3% YoY
Share of the latest fiscal year, largest first. The line is the segment across every fiscal year we have: hover it to read one. “Not broken out” is the remainder, pinned last whatever its size: the named segments reach 85% of reported revenue, and the rest was filed without a segment label at all.
−1.7% YoY
−0.3 pp YoY
−0.3 pp YoY
−9.4% YoY
−0.3 pp YoY
−8.2% YoY
−36.7% YoY
+$210M YoY
| $ billions | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Cash & equivalents | 5.5 | 4.8 | 3.8 | 2.2 | 5.9 |
| Short-term investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Receivables | 1.8 | 1.5 | 1.4 | 1.7 | 1.4 |
| $ billions | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Operating cash flow | 6.6 | 7.4 | 8.6 | 4.0 | 8.6 |
| Capital expenditure | −3.7 | −2.9 | −4.8 | −5.5 | −3.5 |
| Free cash flow | 2.8 | 4.5 | 3.8 |
P/E vs EPS growth · below the channel = cheaper for its growth
P/S vs revenue growth · below the channel = cheaper for its growth
| Ticker | P/E | Fwd P/E | PEG | P/S | Fwd P/S | PSG | EPS gr | Rev gr |
|---|---|---|---|---|---|---|---|---|
| TGT | 16.9 | 22.5 | 4.09 | 0.7 | 0.7 | 0.26 | 6% | 3% |
| CCEP | 21.1 | 24.0 | 2.42 | 1.9 | 2.2 | 0.52 | 10% | 4% |
| ABEV | 15.2 | 2.9 | 0.43 | 2.8 | 0.5 | 0.10 | 7% | 5% |
| KDP | 33.1 | 14.3 | 0.67 | 2.2 | 1.7 | 0.07 | 21% | 23% |
| SYY | 22.1 | 16.0 | 0.95 | 0.5 | 0.4 | 0.09 | 17% | 4% |
| KR | 33.8 | 12.2 | 0.23 | 0.2 | 0.2 | 0.15 | 52% | 1% |
Dots = reported EPS vs consensus · gap = surprise · dashed = estimate ($)
Solid = reported · dashed = forward consensus · shaded = analyst low–high ($B)
Rows: discount rate (r) · Columns: terminal growth (g∞) · cell = fair value, shaded by up/downside vs 164.
Last 12M · $0M bought · $28M sold · net −$28M
| Inventory |
|---|
| 12.3 |
| 12.7 |
| 11.9 |
| 13.5 |
| 13.9 |
| Total current assets | 20.0 | 19.5 | 17.5 | 17.8 | 21.6 |
|---|
| Property, plant & equipment | 37.5 | 36.8 | 36.5 | 34.2 | 30.7 |
|---|
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.4 | 0.5 |
|---|
| Other non-current assets | 2.0 | 1.5 | 1.4 | 0.9 | 1.0 |
|---|
| Total assets | 59.5 | 57.8 | 55.4 | 53.3 | 53.8 |
|---|
| Accounts payable | 12.6 | 13.1 | 12.1 | 13.5 | 15.5 |
|---|
| Short-term debt | 2.1 | 1.6 | 1.1 | 0.1 | 0.2 |
|---|
| Total current liabilities | 21.2 | 20.8 | 19.3 | 19.5 | 21.7 |
|---|
| Long-term debt | 14.3 | 14.3 | 14.9 | 16.0 | 13.5 |
|---|
| Total liabilities | 43.3 | 43.1 | 41.9 | 42.1 | 41.0 |
|---|
| Shareholders’ equity | 16.2 | 14.7 | 13.4 | 11.2 | 12.8 |
|---|
Fiscal year · latest five reported years
| −1.5 |
| 5.1 |
| Investing cash flow | −3.6 | −2.9 | −4.8 | −5.5 | −3.2 |
|---|
| Dividends paid | −2.1 | −2.0 | −2.0 | −1.8 | −1.5 |
|---|
| Share buybacks | −0.4 | −1.0 | −0.1 | −2.6 | −7.2 |
|---|
| Net debt issued / (repaid) | 0.3 | −0.4 | −0.1 | 2.5 | 0.8 |
|---|
| Financing cash flow | −2.2 | −3.5 | −2.3 | −2.2 | −8.1 |
|---|
| Net change in cash | 0.7 | 1.0 | 1.6 | −3.7 | −2.6 |
|---|
Fiscal year · outflows shown negative